Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 148.7B | 159.7B | 144.4B | 140.7B |
Cost of revenue | 127.7B | 136.2B | 122.9B | 118.8B |
Gross profit | 21.1B | 23.5B | 21.5B | 21.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 8.4B | 8.3B | 7.8B | 7.1B |
Operating income | 7.1B | 9.9B | 8.9B | 10.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 189.6M | 182.1M | 163.2M | 159.6M |
Other income expense | — | — | — | — |
Pretax income | 7.2B | 10.0B | 9.0B | 10.5B |
Tax provision | 1.7B | 2.7B | 2.4B | 2.8B |
Net income | 5.5B | 7.2B | 6.6B | 7.7B |
Basic EPS | — | 11.1 | 10.1 | 11.9 |
Diluted EPS | — | 11.1 | 10.1 | 11.4 |
Basic average shares | — | 650.8M | 650.5M | 650.8M |
Diluted average shares | — | 652M | 652.4M | 681.2M |
EBITDA | 9.8B | 12.4B | 11.3B | 12.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | 1.1M | 1.8M | 1.4M | 1.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |